AAAAAA

   
Results: 1-19 |
Results: 19
NEOANTIGENS AND ANTIBODIES TO FACTOR-VIII
Authors: PROWSE CV MACGREGOR IR
Citation: Cv. Prowse et Ir. Macgregor, NEOANTIGENS AND ANTIBODIES TO FACTOR-VIII, Blood reviews, 12(2), 1998, pp. 99-105
MODULATION OF HUMAN ENDOTHELIAL THROMBOMODULIN BY NEUTROPHILS AND THEIR RELEASE PRODUCTS
Authors: MACGREGOR IR PERRIE AM DONNELLY SC HASLETT C
Citation: Ir. Macgregor et al., MODULATION OF HUMAN ENDOTHELIAL THROMBOMODULIN BY NEUTROPHILS AND THEIR RELEASE PRODUCTS, American journal of respiratory and critical care medicine, 155(1), 1997, pp. 47-52
HIGH-PURITY FACTOR-IX AND PROTHROMBIN COMPLEX CONCENTRATE (PCC) - PHARMACOKINETICS AND EVIDENCE THAT FACTOR IXA IS THE THROMBOGENIC TRIGGERIN PCC
Authors: PHILIPPOU H ADAMI A LANE DA MACGREGOR IR TUDDENHAM EGD LOWE GDO RUMLEY A LUDLAM CA
Citation: H. Philippou et al., HIGH-PURITY FACTOR-IX AND PROTHROMBIN COMPLEX CONCENTRATE (PCC) - PHARMACOKINETICS AND EVIDENCE THAT FACTOR IXA IS THE THROMBOGENIC TRIGGERIN PCC, Thrombosis and haemostasis, 76(1), 1996, pp. 23-28
THROMBOGENICITY OF FACTOR-IX CONCENTRATES
Authors: MCLAUGHLIN LF DRUMMOND O MACGREGOR IR
Citation: Lf. Mclaughlin et al., THROMBOGENICITY OF FACTOR-IX CONCENTRATES, Haemophilia, 1, 1995, pp. 16-18
LOW PROTEIN-C AND PROTEIN-S AND ACTIVATION OF FIBRINOLYSIS IN TREATEDESSENTIAL THROMBOCYTHEMIA
Authors: WIECZOREK I MACGREGOR IR LUDLAM CA
Citation: I. Wieczorek et al., LOW PROTEIN-C AND PROTEIN-S AND ACTIVATION OF FIBRINOLYSIS IN TREATEDESSENTIAL THROMBOCYTHEMIA, American journal of hematology, 49(4), 1995, pp. 277-281
CONTROL OF HUMAN ENDOTHELIAL-CELL THROMBOMODULIN METABOLISM BY NEUTROPHILS
Authors: PERRIE AM MACGREGOR IR DONNELLY SC HASLETT C
Citation: Am. Perrie et al., CONTROL OF HUMAN ENDOTHELIAL-CELL THROMBOMODULIN METABOLISM BY NEUTROPHILS, Thrombosis and haemostasis, 73(6), 1995, pp. 899-899
THROMBOGENIC MECHANISMS INVESTIGATED WITH COAGULATION ACTIVATION MARKERS AFTER INFUSION OF FACTOR-IX CONCENTRATES IN PATIENTS WITH HEMOPHILIA-B
Authors: PHILIPPOU H ADAMI A LANE DA MACGREGOR IR TUDDENHAM E RUMLEY A LOWE G LUDLAM C
Citation: H. Philippou et al., THROMBOGENIC MECHANISMS INVESTIGATED WITH COAGULATION ACTIVATION MARKERS AFTER INFUSION OF FACTOR-IX CONCENTRATES IN PATIENTS WITH HEMOPHILIA-B, Thrombosis and haemostasis, 73(6), 1995, pp. 1021-1021
ASSESSMENT OF METHODS FOR DETECTION OF NEOANTIGENS IN BLOOD PRODUCTS
Authors: MCLAUGHLIN LF MACGREGOR IR MACGREGOR MC PEPPER DS PROWSE CV
Citation: Lf. Mclaughlin et al., ASSESSMENT OF METHODS FOR DETECTION OF NEOANTIGENS IN BLOOD PRODUCTS, Thrombosis and haemostasis, 73(6), 1995, pp. 1211-1211
EVALUATION OF A RODENT STASIS MODEL OF THROMBOGENICITY - CORRELATION WITH ESTABLISHED MODELS
Authors: MCLAUGHLIN LF WRIGHT L MACGREGOR IR
Citation: Lf. Mclaughlin et al., EVALUATION OF A RODENT STASIS MODEL OF THROMBOGENICITY - CORRELATION WITH ESTABLISHED MODELS, Thrombosis and haemostasis, 73(6), 1995, pp. 1336-1336
NO DETECTABLE ALTERATIONS IN IMMUNOGENICITY FOLLOWING TERMINAL SEVEREDRY-HEAT TREATMENT OF HIGH-PURITY FACTOR-VIII (LIBERATE) AND FACTOR-IX (HP9) CONCENTRATES
Authors: MACGREGOR IR MCLAUGHLIN LF MACGREGOR MC PROWSE CV PEPPER DS
Citation: Ir. Macgregor et al., NO DETECTABLE ALTERATIONS IN IMMUNOGENICITY FOLLOWING TERMINAL SEVEREDRY-HEAT TREATMENT OF HIGH-PURITY FACTOR-VIII (LIBERATE) AND FACTOR-IX (HP9) CONCENTRATES, Vox sanguinis, 69(4), 1995, pp. 319-327
STUDY OF ENDOTHELIAL T-PA AND VWF IN NORMAL SUBJECTS AND IN VON-WILLEBRANDS DISEASE
Authors: WIECZOREK I LUDLAM CA MACGREGOR IR
Citation: I. Wieczorek et al., STUDY OF ENDOTHELIAL T-PA AND VWF IN NORMAL SUBJECTS AND IN VON-WILLEBRANDS DISEASE, Blood coagulation & fibrinolysis, 5(3), 1994, pp. 329-334
THE LONG-TERM EFFECTS OF METOPROLOL AND EPANOLOL ON TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN PATIENTS WITH ISCHEMIC-HEART-DISEASE
Authors: WRIGHT RA PERRIE AM STENHOUSE F ALBERTI KGMM RIEMERSMA RA MACGREGOR IR BOON NA
Citation: Ra. Wright et al., THE LONG-TERM EFFECTS OF METOPROLOL AND EPANOLOL ON TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN PATIENTS WITH ISCHEMIC-HEART-DISEASE, European Journal of Clinical Pharmacology, 46(3), 1994, pp. 279-282
NEUTRALIZATION OF HEPARIN BY TRASYLOL
Authors: LANE DA MACGREGOR IR PRESTON FE
Citation: Da. Lane et al., NEUTRALIZATION OF HEPARIN BY TRASYLOL, The Annals of thoracic surgery, 58(2), 1994, pp. 604-605
CONSTITUTIVE AND REGULATED RELEASE OF T-PA AND VWF FROM ENDOTHELIAL-CELLS OCCUR THROUGH INDEPENDENT MECHANISMS - EVIDENCE FOR A LINK IN THEREGULATED RELEASE OF T-PA AND VWF
Authors: WIECZOREK I MACGREGOR IR LUDLAM CA
Citation: I. Wieczorek et al., CONSTITUTIVE AND REGULATED RELEASE OF T-PA AND VWF FROM ENDOTHELIAL-CELLS OCCUR THROUGH INDEPENDENT MECHANISMS - EVIDENCE FOR A LINK IN THEREGULATED RELEASE OF T-PA AND VWF, Thrombosis and haemostasis, 69(6), 1993, pp. 644-644
RELATIONSHIP BETWEEN THE LEVEL OF ACTIVATED FACTOR-IX (FIXA) IN FACTOR-IX CONCENTRATES AND THEIR IN-VIVO THROMBOGENICITY IN ANIMAL-MODELS
Authors: MCLAUGHLIN LF DRUMMOND O MACGREGOR IR
Citation: Lf. Mclaughlin et al., RELATIONSHIP BETWEEN THE LEVEL OF ACTIVATED FACTOR-IX (FIXA) IN FACTOR-IX CONCENTRATES AND THEIR IN-VIVO THROMBOGENICITY IN ANIMAL-MODELS, Thrombosis and haemostasis, 69(6), 1993, pp. 1030-1030
INDUCTION OF TISSUE FACTOR EXPRESSION IN HUMAN ENDOTHELIAL-CELLS BY FACTOR-IX CONCENTRATE - CORRELATION WITH AN IN-VIVO THROMBOGENICITY MODEL
Authors: MACGREGOR IR HUNTER NR MCLAUGHLIN LF
Citation: Ir. Macgregor et al., INDUCTION OF TISSUE FACTOR EXPRESSION IN HUMAN ENDOTHELIAL-CELLS BY FACTOR-IX CONCENTRATE - CORRELATION WITH AN IN-VIVO THROMBOGENICITY MODEL, Thrombosis and haemostasis, 69(6), 1993, pp. 1030-1030
PRECLINICAL EVALUATION OF THROMBOGENICITY OF A HIGH-PURITY FACTOR-IX CONCENTRATE
Authors: FELDMAN PA MACGREGOR IR FERGUSON JM MCLAUGHLIN LF SIMS GE
Citation: Pa. Feldman et al., PRECLINICAL EVALUATION OF THROMBOGENICITY OF A HIGH-PURITY FACTOR-IX CONCENTRATE, Thrombosis and haemostasis, 69(6), 1993, pp. 1281-1281
DEFINITION OF EPITOPES WITHIN PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) USING MULTIPLE PEPTIDE-SYNTHESIS
Authors: PERRIE AM MACGREGOR IR BOOTH NA
Citation: Am. Perrie et al., DEFINITION OF EPITOPES WITHIN PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) USING MULTIPLE PEPTIDE-SYNTHESIS, Fibrinolysis, 7(4), 1993, pp. 257-263
CROSS-LINKED FIBRIN DEGRADATION PRODUCTS, PROGRESSION OF PERIPHERAL ARTERIAL-DISEASE, AND RISK OF CORONARY HEART-DISEASE
Authors: FOWKES FGR LOWE GDO HOUSLEY E RATTRAY A RUMLEY A ELTON RA MACGREGOR IR DAWES J
Citation: Fgr. Fowkes et al., CROSS-LINKED FIBRIN DEGRADATION PRODUCTS, PROGRESSION OF PERIPHERAL ARTERIAL-DISEASE, AND RISK OF CORONARY HEART-DISEASE, Lancet, 342(8863), 1993, pp. 84-86
Risultati: 1-19 |